The global cell-penetrating peptide (CPP) market is one of the promising segments for the biotechnology and pharmaceutical companies. This is because increasing numbers of individuals require efficient methods for drug delivery, particularly when the drug is not easily transported across cellular membranes by proteins, nucleic acids or small molecules. CPPs are nearly always cationic and usually quite short peptides which facilitate the entry of these medicinal agents into cells. This renders them more available in the body and potent, and with less side effects as compared to their non-nano counterparts.

Cell Therapy Manufacturing Market relates to the business industry focused on the manufacturing and marketing of therapeutic products from living cells. This involves cell acquisition, culture, growth and testing that forms part of regenerative medicine for diseases including but not limited to cancers and genetic disorders